MetLife Investment Management’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-45,302
Closed -$194K 2377
2019
Q3
$194K Sell
45,302
-3,374
-7% -$12.2K ﹤0.01% 1968
2019
Q2
$145K Buy
+48,676
New +$122K ﹤0.01% 2204

MetLife Investment Management's CVRS Position: Q4 2019 in Review

MetLife Investment Management sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q4 2019, closing a stake of 45,302 shares — an estimated $194K sold.

MetLife Investment Management first reported a position in CVRS in Q2 2019 and held it in 2 quarters. The position peaked at $194K in Q3 2019. 0 funds tracked by Wall St. Rank hold CVRS as of Q4 2019.

  • MetLife Investment Management reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q4 2019 after selling out during the quarter.
  • MetLife Investment Management sold 45,302 CORINDUS VASCULAR ROBOTICS, INC shares in Q4 2019, an estimated $194K.
  • MetLife Investment Management first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q2 2019 and held it in 2 quarters.
  • MetLife Investment Management's CORINDUS VASCULAR ROBOTICS, INC position peaked at $194K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q4 2019.

Based on MetLife Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.